Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/26363

Title:	Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel.
Authors:	Martínez-Jañez, Noelia Chacón, Ignacio de Juan, Ana Cruz-Merino, Luis Del Barco, Sònia Fernández, Isaura García-Teijido, Paula Gómez-Bernal, Amalia Plazaola, Arrate Ponce, José Servitja, Sonia Zamora, Pilar View more
Keywords:	Anti-HER2 Clinical practice Metastatic breast cancer View more
Issue Date:	Apr-2016
Citation:	Breast Care (Basel).2016 Apr;(11)2:133-8
Abstract:	The aim of this project was to provide an expert opinion regarding anti-human epidermal growth factor receptor 2 (HER2) therapy beyond second-line treatment of metastatic breast cancer (mBC).
PMID:	27239176
URI:	https://hdl.handle.net/20.500.12530/26363
Rights:	openAccess
ISSN:	1661-3791
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:

File	Description	Size	Format
PMC4881249.pdf		108.68 kB	Adobe PDF	View/Open